Combined preparations comprising morpholine anthracyclines and anticancer agent
US6586428B2 · kind B2 · utility
23Cited by
2References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 31, 2002 |
| Grant date | Jul 1, 2003 |
| Priority date | — |
| Expiry date | Oct 31, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to combined preparations comprising a morpholinyl anthracycline administered in combination anticancer agents chosen from an alkylating agent, an antimetabolite, a topoisomerase II inihbitor, a topoisomerase I inhibitor, an antimitotic drug and a platinum derivative, which are useful anticancer therapy, particularly in the treatment of a primary or metastatic liver cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.